MDR-1 and GST polymorphisms are involved in myelodysplasia progression (2013)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.leukres.2013.04.024
- Subjects: IDOSOS; DOENÇAS HEMATOLÓGICAS; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Source:
- Título: Leukemia Research
- ISSN: 0145-2126
- Volume/Número/Paginação/Ano: v. 37, n. 8, p. 970-973, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PALODETTO, Bruna et al. MDR-1 and GST polymorphisms are involved in myelodysplasia progression. Leukemia Research, v. 37, n. 8, p. 970-973, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.04.024. Acesso em: 24 jan. 2026. -
APA
Palodetto, B., Campos, P. de M., Benites, B. D., Chauffaille, M. de L. L. F., Velloso, E. D. R. P., Traina, F., & Saad, S. T. O. (2013). MDR-1 and GST polymorphisms are involved in myelodysplasia progression. Leukemia Research, 37( 8), 970-973. doi:10.1016/j.leukres.2013.04.024 -
NLM
Palodetto B, Campos P de M, Benites BD, Chauffaille M de LLF, Velloso EDRP, Traina F, Saad STO. MDR-1 and GST polymorphisms are involved in myelodysplasia progression [Internet]. Leukemia Research. 2013 ; 37( 8): 970-973.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.leukres.2013.04.024 -
Vancouver
Palodetto B, Campos P de M, Benites BD, Chauffaille M de LLF, Velloso EDRP, Traina F, Saad STO. MDR-1 and GST polymorphisms are involved in myelodysplasia progression [Internet]. Leukemia Research. 2013 ; 37( 8): 970-973.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.leukres.2013.04.024 - Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome
- STMN1 (stathmin 1)
- Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
- Differential profile of PIP4K2A expression in hematological malignancies
- FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
- Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression
Informações sobre o DOI: 10.1016/j.leukres.2013.04.024 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
